Through this Invitation for Bids (“IFB”), the New York State Office of Addiction Services and Supports (NYS OASAS) is seeking competitive bids from (a) eligible organization(s) to provide Food and Drug Administration (FDA) approved intranasal naloxone product, 4 mg per 0.1 mL solution, to NYS OASAS-Approved Providers and related organizations through an online ordering and tracking portal maintained by the bidder. It is the intent of NYS OASAS to make one (1) award from this procurement.
Any resulting award will allow for the purchase of Naloxone on an as needed basis, with no guarantee of any purchases, and will be issued as a Purchase Authorization (PA). NYS OASAS anticipates that the initial PA will be for up to $8.0M, however NYS OASAS reserves the right to increase the PA amount if additional Naloxone is needed contingent on all required approvals.
Proposals must be emailed to [email protected]. The subject of the email should read: IFB 25019, "Bidder Name." Complete proposals must be received by NYS OASAS by the Bid Submission due date and time found in the Expected Timeline for Key Events of this IFB.
Amended 4/6/2026 - Checklist of Submission Requirements (optional, but highly recommended)
Download